Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Sight Sciences, Inc. (SGHT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/03/2023 |
8-K
| Investor presentation, Quarterly results
Docs:
|
"Condensed Consolidated Balance Sheets June 30, December 31, 2023 2022 Assets Current assets: Cash and cash equivalents $ 154,515 $ 185,000 Accounts receivable, net of allowance for credit losses of $1,037 and $1,024 at June 30, 2023 and December 31, 2022, respectively 18,103 15,148 Inventory, net 7,907 6,114 Prepaid expenses and other current assets 1,795 3,415 Total current assets 182,320 209,677 Property and equipment, net 1,477 1,571 Operating lease right-of-use assets 1,125 1,614 Other noncurrent assets 367 211 Total assets $ 185,289 $ 213,073 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 2,947 $ 2,688 Accrued compensation 5,720 7,352 Accrued and other current liabilities 5,386 7,777 Total current liabilities 14,053 17,817 Long-term debt 33,607 33,313 Ot...",
"DELIVERING THE POWER OF SIGHT" |
|
03/13/2023 |
8-K
| Quarterly results
Docs:
|
"SIGHT SCIENCES, INC. Condensed Consolidated Balance Sheets December 31, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 185,000 $ 260,687 Accounts receivable, net 15,148 8,709 Inventory, net 6,114 3,475 Prepaid expenses and other current assets 3,415 4,164 Total current assets 209,677 277,035 Property and equipment, net 1,571 1,454 Operating lease right-of-use assets 1,614 1,495 Other noncurrent assets 211 202 Total assets $ 213,073 $ 280,186 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 2,688 $ 3,351 Accrued compensation 7,352 5,987 Accrued and other current liabilities 7,777 4,166 Total current liabilities 17,817 13,504 Long-term debt 33,313 32,656 Other noncurrent liabilities 1,867 1,919 Total liabilities 52,997 48,079 Commitment..." |
|
11/10/2022 |
8-K
| Quarterly results
Docs:
|
"SIGHT SCIENCES, INC. Condensed Consolidated Balance Sheets September 30, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 199,819 $ 260,687 Accounts receivable, net 12,593 8,709 Inventory, net 5,520 3,475 Prepaid expenses and other current assets 4,411 4,164 Total current assets 222,343 277,035 Property and equipment, net 1,568 1,454 Operating lease right-of-use assets 1,121 1,495 Other noncurrent assets 202 202 Total assets $ 225,234 $ 280,186 Liabilities, redeemable convertible preferred stock, and Stockholders’ equity Current liabilities: Accounts payable $ 3,239 $ 3,351 Accrued compensation 7,993 5,987 Accrued and other current liabilities 6,154 4,166 Total current liabilities 17,386 13,504 Long-term debt 33,158 32,656 Other noncurrent liabilities 1,751 1,919 ..." |
|
08/11/2022 |
8-K
| Quarterly results |
05/10/2022 |
8-K
| Quarterly results |
11/10/2021 |
8-K
| Quarterly results
Docs:
|
"SIGHT SCIENCES, INC. Condensed Consolidated Balance Sheets September 30, December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 271,475 $ 61,511 Accounts receivable, net 8,920 5,363 Inventory, net 2,948 2,598 Prepaid expenses and other current assets 4,493 1,161 Total current assets 287,836 70,633 Property and equipment, net 1,420 1,269 Operating lease right-of-use assets 1,612 518 Other noncurrent assets 182 386 Total assets $ 291,050 $ 72,806 Liabilities, redeemable convertible preferred stock, and stockholders’ equity Current liabilities: Accounts payable $ 1,839 $ 2,158 Accrued compensation 4,639 4,070 Accrued and other current liabilities 3,837 3,086 Total current liabilities 10,315 9,314 Long-term debt 32,486 31,955 Other noncurrent liabilities 2,273 3,055 Total l..." |
|
08/12/2021 |
8-K
| Quarterly results |
|
|